Allon Therapeutics, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2012
Allon Therapeutics, Inc. reported unaudited earnings results for the third quarter and nine months ended September 30, 2012. The company reported a net loss of $1,847,863 or $0.01 per share for the three months ended September 30, 2012, compared to a net loss of $2,983,887 or $0.04 per share for the three months ended September 30, 2011, representing a decrease in net loss of $1,136,024.
For the nine months ended September 30, 2012, the company reported a net loss of $7,869,780 or $0.07 per share, compared to a net loss of $8,877,797 or $0.11 per share for the nine months ended September 30, 2011.